On March 21, the FDA posted a summary on its website detailing the changes and classified the move as the “most serious type of recall” because of the risk of serious injuries or death if the device is used incorrectly. Even though the FDA referred to a recall, the device will remain on the market. The New York Times first reported details of the Impella pump.
J and J also report in Washington post of $10 bill cardio deal!,
!
On March 21, the FDA posted a summary on its website detailing...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.000(0.00%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | $1.13 | $1.07 | $290.6K | 250K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 28301 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 11196 | 1 |
View Market Depth
| Last trade - 09.51am 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
0.000 ( 4.25 %) |
||||
| Open | High | Low | Volume | ||
| $1.16 | $1.19 | $1.16 | 110069 | ||
| Last updated 10.10am 22/05/2024 ? | |||||
| MSB (ASX) Chart |
Day chart unavailable